Non-Antibody Products — page 84 of 94
Non-Antibody Products
Page 84 of 94
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| Z-VA-DL-D(OMe)-FMK (trifluoroacetate salt) | Jurkat T lymphocytes at 0.5 µM; inhibits cell death induced by TNF-… | 1 mg | 27421-1 |
 CAYMAN CHEMICAL COMPANY |
More Info |
| Z-VA-DL-D(OMe)-FMK (trifluoroacetate salt) | Jurkat T lymphocytes at 0.5 µM; inhibits cell death induced by TNF-… | 500 µg | 27421-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| E-64d | scrapie-infected neuroblastoma cells (IC50 = 0.5 µM); inhibits SARS… | 1 mg | 13533-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| E-64d | scrapie-infected neuroblastoma cells (IC50 = 0.5 µM); inhibits SARS… | 10 mg | 13533-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| E-64d | scrapie-infected neuroblastoma cells (IC50 = 0.5 µM); inhibits SARS… | 25 mg | 13533-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| E-64d | scrapie-infected neuroblastoma cells (IC50 = 0.5 µM); inhibits SARS… | 5 mg | 13533-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| DL-2,6-dimethyl Heptanoic Acid | block in the synthesis of 2,6-dimethyl heptanoyl-CoA | 10 mg | 24822-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| DL-2,6-dimethyl Heptanoic Acid | block in the synthesis of 2,6-dimethyl heptanoyl-CoA | 25 mg | 24822-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| DL-2,6-dimethyl Heptanoic Acid | block in the synthesis of 2,6-dimethyl heptanoyl-CoA | 5 mg | 24822-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| DL-2,6-dimethyl Heptanoic Acid | block in the synthesis of 2,6-dimethyl heptanoyl-CoA | 50 mg | 24822-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SCD5 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-106535-V |
 SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| ECH1 shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-143282-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| PACRG shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-61277-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Mitoxantrone (hydrochloride) | SARS-CoV-2 spike glycoprotein; inhibits the entry of SA… | 10 mg | 14842-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Mitoxantrone (hydrochloride) | SARS-CoV-2 spike glycoprotein; inhibits the entry of SA… | 100 mg | 14842-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Mitoxantrone (hydrochloride) | SARS-CoV-2 spike glycoprotein; inhibits the entry of SA… | 50 mg | 14842-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Mitoxantrone (hydrochloride) | SARS-CoV-2 spike glycoprotein; inhibits the entry of SA… | 500 mg | 14842-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| ACOT4 shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-72438-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| PHYHIP shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-77550-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| von Willebrand Factor, human | Principle of the Assay: Acetyl-CoA can react with choline under t… | 5 plates | MBS512201 |
 MYBIOSOURCE INC. |
More Info |
| VV116 | VV116, also known as JT001, is an oral drug candidate of nucleoside analog… | 100 mg, 25 mg, 10 mg | orb1473047 |
 BIORBYT LTD. |
More Info |
| Bofutrelvir | supernatant of SARS-CoV-2-infected Vero E6 cells (EC50… | 1 mg | 31344-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Bofutrelvir | supernatant of SARS-CoV-2-infected Vero E6 cells (EC50… | 10 mg | 31344-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Bofutrelvir | supernatant of SARS-CoV-2-infected Vero E6 cells (EC50… | 5 mg | 31344-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| ACSL1 shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-60616-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| ECHDC1 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-95653-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Bafilomycin A1 | -2 Nsp6 and M; Inhibits SARS-CoV-2 in cells. Pl… | 100 µg, 1 mg, | abx076625 |
 ABBEXA LTD |
More Info |
| Abiraterone Acetate | at 0.1 and 0.5 mmol / kg per day; reduces SARS-CoV-2 vi… | 10 mg | 15148-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Abiraterone Acetate | at 0.1 and 0.5 mmol / kg per day; reduces SARS-CoV-2 vi… | 25 mg | 15148-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Abiraterone Acetate | at 0.1 and 0.5 mmol / kg per day; reduces SARS-CoV-2 vi… | 5 mg | 15148-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Abiraterone Acetate | at 0.1 and 0.5 mmol / kg per day; reduces SARS-CoV-2 vi… | 50 mg | 15148-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Emvododstat | -A synthesis in HeLa cells (EC50 = 1.64 nM); inhibits viral replication of… | 1 mg | 36877-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Emvododstat | -A synthesis in HeLa cells (EC50 = 1.64 nM); inhibits viral replication of… | 10 mg | 36877-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Emvododstat | -A synthesis in HeLa cells (EC50 = 1.64 nM); inhibits viral replication of… | 5 mg | 36877-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SBP1 (trifluoroacetate salt) | phosphate in vivo; increases network capture efficiency of SARS-CoV
| 1 mg |
37469-1 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| SBP1 (trifluoroacetate salt) | phosphate in vivo; increases network capture efficiency of SARS-CoV
| 10 mg |
37469-10 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| SBP1 (trifluoroacetate salt) | phosphate in vivo; increases network capture efficiency of SARS-CoV
| 25 mg |
37469-25 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| SBP1 (trifluoroacetate salt) | phosphate in vivo; increases network capture efficiency of SARS-CoV
| 5 mg |
37469-5 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| NMT2 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-61134-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Bexarotene | load in the culture supernatant of Vero E6 cells infected with SARS-C… | 10 mg | 11571-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Bexarotene | load in the culture supernatant of Vero E6 cells infected with SARS-C… | 100 mg | 11571-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Bexarotene | load in the culture supernatant of Vero E6 cells infected with SARS-C… | 25 mg | 11571-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Bexarotene | load in the culture supernatant of Vero E6 cells infected with SARS-C… | 50 mg | 11571-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Cetilistat | ; reduces viral load in the culture supernatant of Vero E6 cells infected… | 10 g | 31622-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Cetilistat | ; reduces viral load in the culture supernatant of Vero E6 cells infected… | 100 g | 31622-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Cetilistat | ; reduces viral load in the culture supernatant of Vero E6 cells infected… | 25 g | 31622-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Cetilistat | ; reduces viral load in the culture supernatant of Vero E6 cells infected… | 50 g | 31622-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| PD 404182 | An antiviral agent; inhibits SARS-CoV-2 Mpro activity (I… | 10 mg | 34396-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| PD 404182 | An antiviral agent; inhibits SARS-CoV-2 Mpro activity (I… | 25 mg | 34396-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| PD 404182 | An antiviral agent; inhibits SARS-CoV-2 Mpro activity (I… | 5 mg | 34396-5 |
CAYMAN CHEMICAL COMPANY |
More Info |